Mid-size CRO SynChem is a mid-sized chemistry-focused contract research organization with a solid track record (over 4,500 projects, multiple publications, and 4 US patents). This suggests repeatable CRO capabilities and potential for ongoing outsourcing of synthetic chemistry, process development, and medicinal chemistry work from pharma and biotech clients.

Growth signals Annual revenue in the 10 to 25 million range and a long-standing history since 1997 indicate a stable business model with potential for expansion partnerships, especially with mid-cap pharma, biotech startups, and companies seeking dedicated chemistry outsourcing.

Global network fit Headquartered near Chicago with experience serving multinational pharmaceutical and chemical clients implies capacity to support North America–focused development programs and potential to scale through partnerships, co-development, or milestone-driven outsourcing deals.

Innovation track A portfolio including medicinal chemistry and process development, plus patents and publications, signals unique chemistry expertise that can be positioned for specialized contract wins such as complex synthesis, scalable routes, and optimization projects for customers facing synthetic challenges.

Tech enablement Routine use of common enterprise tech and web infrastructure (Google Workspace, analytics tags, secure web practices) suggests a modern operational backbone that can be paired with digital outreach, collaboration platforms, and streamlined vendor onboarding to accelerate sales cycles.